sanofi-aventis

(NYSE:SNY)

View:
Quarterly Data
Annual Data
Note: All numbers in thousands

	Jun 30, 2008	Mar 31, 2008	Dec 31, 2007	Sep 30, 2007
Operating revenue
Total Revenue	11,180,000	11,204,000	12,556,000	9,946,000
Operating Revenue	11,180,000	11,204,000	12,556,000	9,946,000
Adjustments To Revenue	—	—	—	—
Cost Of Sales	2,399,000	—	—	—
Cost Of Sales With Depreciation	2,846,000	—	—	—
Gross Operating Profit	8,781,000	11,204,000	—	9,946,000
Operating Expenses
Research And Development Expenses	1,716,000	—	—	—
Selling General And Administrative Expenses	2,813,000	—	—	—
Advertising Expenses	—	—	—	—
Operating Income Before Depreciation	4,252,000	11,204,000	—	9,946,000
Operating Income	2,335,000	—	—	—
Depreciation	1,792,000	—	—	—
Depreciation Unreconciled	—	—	—	—
Amortization	—	—	—	—
Amortization Of Intangibles	1,345,000	—	—	—
Operating Income After Depreciation	2,460,000	11,204,000	—	9,946,000
Non Operating Expenses
Interest Expense	126,000	—	—	—
Pre Tax Income	2,621,000	11,204,000	—	9,946,000
Income Taxes	607,000	—	—	—
Minority Interest	173,000	—	—	—
Income Before Income Taxes	2,295,000	—	—	—
Net Income From Continuing Operations	1,841,000	1,842,000	2,028,000	1,854,000
Net Income From Discontinued Operations	—	—	—	—
Net Income From Total Operations	1,841,000	1,842,000	2,028,000	1,854,000
Non Recurring Events
Extraordinary Income Losses	—	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—	—
Income From Tax Loss Carryforward	—	—	—	—
Other Gains And Losses	—	—	—	—
Total Net Income	1,841,000	1,842,000	2,028,000	1,854,000
Normalized Income	2,103,000	—	—	—
NetIncome Available For Common	1,841,000	1,842,000	—	1,854,000
Preferred Dividends	—	—	—	—
Excise Taxes	—	—	—	—

	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004
Operating revenue
Total Revenue	42,651,000	38,920,000	33,745,000	20,377,000
Operating Revenue	42,651,000	38,920,000	33,745,000	20,377,000
Adjustments To Revenue	—	—	—	—
Cost Of Sales	9,581,000	7,222,000	6,689,000	4,186,000
Cost Of Sales With Depreciation	11,056,000	10,013,000	8,954,000	5,084,000
Gross Operating Profit	33,070,000	31,698,000	27,056,000	16,191,000
Operating Expenses
Research And Development Expenses	6,625,000	5,847,000	4,786,000	10,099,000
Selling General And Administrative Expenses	11,479,000	10,585,000	9,764,000	6,096,000
Advertising Expenses	—	—	—	—
Operating Income Before Depreciation	14,966,000	15,266,000	12,506,000	-4,000
Operating Income	8,632,000	7,561,000	5,625,000	-413,000
Depreciation	6,811,000	8,068,000	7,043,000	3,411,000
Depreciation Unreconciled	—	—	—	—
Amortization	—	—	—	—
Amortization Of Intangibles	5,336,000	5,277,000	4,778,000	2,513,000
Operating Income After Depreciation	8,155,000	7,198,000	5,463,000	-3,415,000
Non Operating Expenses
Interest Expense	480,000	601,000	630,000	—
Pre Tax Income	9,301,000	6,860,000	3,634,000	-3,792,000
Income Taxes	1,003,000	1,056,000	565,000	1,109,000
Minority Interest	612,000	519,000	396,000	-9,000
Income Before Income Taxes	8,429,000	6,266,000	3,128,000	-2,497,000
Net Income From Continuing Operations	7,686,000	5,287,000	2,672,000	-4,890,000
Net Income From Discontinued Operations	—	—	—	—
Net Income From Total Operations	7,686,000	5,287,000	2,672,000	-4,890,000
Non Recurring Events
Extraordinary Income Losses	—	—	—	—
Income From Cummulated Effect Of Accounting Changes	—	—	—	—
Income From Tax Loss Carryforward	—	—	—	—
Other Gains And Losses	—	—	—	—
Total Net Income	7,686,000	5,287,000	2,672,000	-4,890,000
Normalized Income	7,971,000	7,184,000	4,972,000	-4,345,000
NetIncome Available For Common	7,686,000	5,287,000	2,672,000	-4,890,000
Preferred Dividends	—	—	—	—
Excise Taxes	—	—	—	—